Hybrid Lipoplex Boosts Neuron‐Microglia Crosstalk for Treatment of Alzheimer's Disease through A β ‐Targeted‐Autophagy and ApoE2 Gene Supplementation
- 29 April 2025
- journal article
- Published by Wiley in Advanced Materials
- Vol. 37 (27) , e2418560
Abstract
Efficient clearance of amyloid‐ β (A β ) is vital but challenging in Alzheimer's disease (AD) treatment due to its complicated regulation mechanisms during generation and metabolism. It necessitates a multidimensional synergistic strategy based on ingenious delivery system design. Herein, guanidine‐rich lipids (metformin‐inspired MLS and arginine‐contained RLS) are devised to trigger selective chaperone‐mediated autophagy for amyloid precursor protein degradation in neurons. They are further co‐assembled with oleic acid‐modified cerium dioxide (OA@CeO 2 ) to form RMC assembly for pApoE2 delivery (RMC/pApoE2 lipoplex). The OA@CeO 2 boosts macro‐autophagy, alleviates oxidative stress and inflammatory microenvironment, and promotes the neurons‐microglia crosstalk for A β elimination. Concurrently, both guanidine‐rich lipids and OA@CeO 2 benefit pApoE2 transfection in neurons, enabling the transport of A β into microglia, and facilitating enzymatic hydrolysis and cellular digestion of extracellular A β . The lipoplex‐boosted neuron–microglia interactions ultimately eliminate both intra‐ and extra‐cellular A β aggregates. Consequently, the RMC/pApoE2 lipoplex eliminates ≈86.9% of A β plaques in the hippocampus of APP/PS1 mice and restored the synaptic function and neuronal connectivity. Moreover, it recovers the spatial memory of APP/PS1 mice to nearly the level of WT control. The presented hybrid lipoplex showcases an advanced gene delivery system, and offers a promising strategy for A β clearance in AD treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81873921)
- National Natural Science Foundation of China (82372027)
- National Natural Science Foundation of China (51933011)
This publication has 79 references indexed in Scilit:
- Harnessing Nanochaperone‐Mediated Autophagy for Selective Clearance of Pathogenic Tau Protein in Alzheimer's DiseaseAdvanced Materials, 2024
- Co‐Assembled Nanoparticles toward Multi‐Target Combinational Therapy of Alzheimer's Disease by Making Full Use of Molecular Recognition and Self‐AssemblyAdvanced Materials, 2024
- Hybrid Membrane‐Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's DiseaseAdvanced Science, 2024
- A Bioactive and Photoresponsive Platform for Wireless Electrical Stimulation to Promote NeurogenesisAdvanced Healthcare Materials, 2022
- “Drug‐Carrier” Synergy Therapy for Amyloid‐β Clearance and Inhibition of Tau Phosphorylation via Biomimetic Lipid Nanocomposite AssemblyAdvanced Science, 2022
- Self‐Catalytic Small Interfering RNA Nanocarriers for Synergistic Treatment of Neurodegenerative DiseasesAdvanced Materials, 2021
- Binding to Amyloid‐β Protein by Photothermal Blood‐Brain Barrier‐Penetrating Nanoparticles for Inhibition and Disaggregation of FibrillationAdvanced Functional Materials, 2021
- Microglial autophagy is impaired by prolonged exposure to β-amyloid peptides: evidence from experimental models and Alzheimer’s disease patientsGeroScience, 2020
- Custom‐Made Ceria Nanoparticles Show a Neuroprotective Effect by Modulating Phenotypic Polarization of the MicrogliaAngewandte Chemie International Edition, 2018
- BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic PlasticityCellular and Molecular Neurobiology, 2017